Raqualia Pharma Incorporated operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Raqualia Pharma Incorporated with three other
companies in this sector in Japan:
Gene Techno Science Co Ltd
sales of 1.09 billion Japanese Yen [US$9.87 million]
PhoenixBio Co Ltd
(1.23 billion Japanese Yen [US$11.13 million]
Medinet Co., Ltd.
(1.70 billion Japanese Yen [US$15.44 million]
of which 100%
was cell processing).
During the year ended December of 2017, sales at
Raqualia Pharma Incorporated were ¥1.42 billion (US$12.86 million).
increase of 101.2%
versus 2016, when the company's sales were ¥705.24 million.